期刊论文分享

学术资料共享,永久免费平台
最新公告:
本站所有期刊杂志信息均包含杂志社真实投稿电话,以及投稿邮箱,投稿请点击以上期刊栏目选择相应期刊直接联系杂志社。
福建冶金 冶金环境保护 太钢译文 有色金属 冶金设备管理与维修 太钢科技 <-->

康复治疗学论文

论文栏目:康复医学论文来源:互联网时间:2018-05-11 10:04

  康复治疗学论文_康复新液治疗肺结核肝功异常110例疗效观察

  【摘 要】目的:对比康复新液配合复方甘草酸苷治疗肺结核肝功异常,与单用复方甘草酸苷治疗肺结核肝功异常的临床疗效。方法:将220例确诊肺结核肝功异常患者随机分为治疗组与对照组,各110例。治疗组采用口服康复新液配合复方甘草酸苷治疗,对照组单用复方甘草酸苷治疗,观察治疗前后疗效,疗程,临床症状及肺部病灶好转,复发率等。结果:治疗组及对照组有效率分别为:91.81%和78.18%,治疗组明显优于对照组,治疗组在治疗疗程,临床症状以及肺部病灶好转和复发率方面也优于对照组,两组比较,差异有统计学意义(P<0.05)。结论:康复新液配合复方甘草酸苷治疗肺结核肝功异常,疗效显著,并可缩短疗程,促进肺部病灶及临床症状好转,减少复发率。

  【关键词】肺结核肝功异常;康复新液;保肝治疗;复方甘草酸苷

  【中图分类号】R522 【文献标识码】B 【文章编号】1003-5028(2015)8-0703-02

  【Abstract】Objective To compare the Kangfuxin Liquid Combined with Compound Glycyrrhizin in the treatment of pulmonary tuberculosis with abnormal liver function, and single compound glycyrrhizin in the treatment of clinical curative effect of pulmonary tuberculosis of abnormal liver function.Methods 220 cases of abnormal liver function in patients with the diagnosis of pulmonary tuberculosis were randomly divided into treatment group and control group, each of 110 cases. The treatment group was treated with Kangfuxin Liquid Combined with Compound Glycyrrhizin in the treatment, control group with single compound glycyrrhizin treatment, course of treatment were observed before and after treatment, curative effect, improvement of clinical symptoms and pulmonary lesions, relapse rate. Results in the treatment group and the control group effective rate were: 91.81% and 78.18%, the treatment group was significantly better than the control group, the treatment group in the course of treatment, the clinical symptoms and pulmonary lesions improvedand the recurrence rate is better than that of the control group, the two groups, the difference was statistically significant (P<0.05). Conclusion Kangfuxin Liquid Combined with Compound Glycyrrhizin in the treatment of pulmonary tuberculosis with abnormal liver function, obvious curative effect

特别说明:本网站内容都来源于互联网,供浏览者学习、欣赏,使用原则非商业性或非盈利性用途,使用者不得侵犯本网站及相关权利人的合法权利。此外,使用者如对本网站内容用于其他用途时,须征得本网站及相关权力人的许可。

本网站内容原作者如不愿意在本网站刊登内容,请及时通知本站,予以删除。


专业论文发表